JB Pharma’s Q2 results propel stock to 52-week high; Should you buy, hold or sell the stock-

JB Chemicals &Pharmaceuticals’ shares soared over 5% to hit a fresh 52-week high of Rs 1,536.25 a day after the company posted a 36% surge in profit after tax at Rs 151 crore in the second quarter of FY25 compared to Rs 111 crore in Q2FY23. The company’s revenue in the quarter under review stood at Rs 882 crore, as against Rs 809 crore in the corresponding period a year ago, JB …

Read more

Historical data indicated markets might end January in red; Nifty range seen between 22240-22400

By Anand James

History suggests that an entry into the earning season with indices at new record peaks, or at month highs, presents a high chance of a monthly close in the red. That said, we may be riding on exceptions this month, as the Santa rally looks to have passed on the baton to the election wave. However, while these two aspects have been propping up sentiments in the last…

Read more